The global pressure monitoring market size was USD 11.79 billion in 2023, calculated at USD 12.78 billion in 2024 and is expected to be worth around USD 28.69 billion by 2034. The market is slated to expand at 8.42% CAGR from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pressure Monitoring Market
5.1. COVID-19 Landscape: Pressure Monitoring Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pressure Monitoring Market, By Product
8.1. Pressure Monitoring Market Revenue and Volume Forecast, by Product, 2024-2033
8.1.1. BP Monitors/Cardiac Pressure Monitors
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Pulmonary Pressure Monitors
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Intraocular Pressure Monitors
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Intracranial Pressure Monitors
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Pressure Monitoring Market, By Procedure
9.1. Pressure Monitoring Market Revenue and Volume Forecast, by Procedure, 2024-2033
9.1.1. Noninvasive
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Invasive
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Pressure Monitoring Market, By Application
10.1. Pressure Monitoring Market Revenue and Volume Forecast, by Application, 2024-2033
10.1.1. Respiratory Disorders
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Glaucoma
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Cardiac Disorders
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Neurological Disorders
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Dialysis
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Pressure Monitoring Market, By End-use
11.1. Pressure Monitoring Market Revenue and Volume Forecast, by End-use, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Home Care Settings
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Ambulatory Surgical Centers & Clinics
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Diagnostic Laboratories
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1.5. Others
11.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Pressure Monitoring Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 13. Company Profiles
13.1. Philips Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. GE Healthcare
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Welch Allyn, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Medtronic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Dragerwerk
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Omron Healthcare Welch Allyn, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. A&D Medical Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. SunTech Medical, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. American Diagnostics Corp.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Withings
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample